opc 12759 has been researched along with Lung Diseases, Interstitial in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajihara, H | 1 |
| Yoshinaga, T | 1 |
| Usijima, S | 1 |
1 other study available for opc 12759 and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Case of drug-induced lung injury due to Rebamipide].
Topics: Aged; Alanine; Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Humans; Lung; Lung Diseases, Inte | 2006 |